Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.
The Centers for Disease Control and Prevention (CDC) today released new data showing a total of 1,033,994 reports of adverse events following COVID vaccines were submitted between Dec. 14, 2020, and Jan. 1, 2022, to the Vaccine Adverse Event Reporting System (VAERS). VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 21,745 reports of deaths — an increase of 363 over the previous week — and 170,446 reports of serious injuries, including deaths, during the same time period — up 3,840 compared with the previous week.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 9,936 U.S. deaths reported as of Jan. 7, 19% occurred within 24 hours of vaccination, 24% occurred within 48 hours of vaccination and 61% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 516 million COVID vaccine doses had been administered as of Jan. 7, including 303 million doses of Pfizer, 197 million doses of Moderna and 18 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed. Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2022, for 5- to 11-year-olds show:
The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.
- 14 reports of myocarditis and pericarditis (heart inflammation).
- 22 reports of blood clotting disorders.
U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2022, for 12- to 17-year-olds show:
The most recent death involves a 15-year-old girl from Minnesota (VAERS I.D. 1974744), who died 177 days after receiving her second dose of Pfizer from a pulmonary embolus. An autopsy is pending.
- 62 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 96% of cases
attributed to Pfizer’s vaccine.
- 589 reports of myocarditis and pericarditis with 578 cases attributed to Pfizer’s vaccine.
- 149 reports of blood clotting disorders, with all cases attributed to Pfizer.
U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2022, for all age groups combined, show:
- 19% of deaths were related to cardiac disorders.
- 55% of those who died were male, 42% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 72.6.
- As of Jan. 7, 4,806 pregnant women reported adverse events related to COVID vaccines, including 1,533 reports of miscarriage or premature birth.
- Of the 3,419 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 41% to Moderna and 8% to J&J.
- 836 reports of Guillain-Barré syndrome (GBS), with 41% of cases attributed to Pfizer, 30% to Moderna and 28% to J&J.
- 2,256 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 12,331 reports of blood clotting disorders in the U.S. Of those, 5,457 reports were attributed to Pfizer, 4,398 reports to Moderna and 2,428 reports to J&J.
- 3,688 cases of myocarditis and pericarditis with 2,269 cases attributed to Pfizer, 1,249 cases to Moderna and 158 cases to J&J’s COVID vaccine.
26-year-old man dies from myocarditis caused by Pfizer COVID vaccine
A 26-year-old South Dakota man died Nov. 12, 2021, of myocarditis, just four days after receiving a booster dose of Pfizer’s COVID vaccine. Joseph Keating had no idea he was experiencing a rare and supposedly “mild” heart problem after the shot.
His only warning signs were fatigue, muscle soreness and an increased heart rate, family members said.
In an exclusive interview Jan. 11 with The Defender, Joseph’s father, mother and sister said the CDC had not investigated Joseph’s death, nor did the agency contact the pathologist who performed the autopsy or request the documents which confirmed Joseph’s death was caused by the Pfizer vaccine.
In an exclusive interview with The Defender, Joseph Keating’s mother said her son’s only warning signs were fatigue, muscle soreness and an increased heart rate, yet an autopsy confirmed he died of myocarditis directly caused by Pfizer’s COVID vaccine.https://t.co/Htk7GHXz6o
— Robert F. Kennedy Jr (@RobertKennedyJr) January 11, 2022
Supreme Court strikes down OSHA mandate, allows healthcare mandate to proceed
The U.S. Supreme Court on Thursday issued two opinions on the Biden administration’s COVID vaccine mandates on whether to stay or to grant temporary injunctions requested by plaintiffs in a number of lawsuits challenging the emergency mandates for millions of Americans.
First, the justices rejected the Biden administration’s mandate requiring employees of large businesses to be vaccinated against COVID or undergo weekly testing and wear a mask indoors while working.
The court’s conservative majority said the administration overstepped its authority by imposing the Occupational Safety and Health Administration’s (OSHA) vaccine-or-test rule on U.S. businesses with at least 100 employees.
In a second ruling, the justices said the mandates for workers in healthcare facilities that receive Medicare or Medicaid funding could stay in place while the lawsuits work their way through the lower courts.
The mandate is estimated to affect 10.3 million healthcare workers in the U.S., but allows for religious and medical exemptions.
Pfizer CEO says 2 shots offer ‘very limited protection, if any’ against COVID
During an interview on CNBC’s “Squawk Box” on Monday, Pfizer CEO Albert Bourla said two doses of Pfizer’s COVID vaccine — initially referred to as a full regimen — “offers very limited protection, if any” against the Omicron variant.
When a third, or booster dose, is administered the vaccine offers only “reasonable protection” against hospitalization and death from Omicron and “less protection against infection,” Bourla said.
Bourla previously claimed a two-dose regimen was “100% effective.”
EU regulators, WHO call for end of boosters
European Union drug regulators on Tuesday warned frequent COVID boosters could risk overloading the immune system and said there are currently no data to support repeated doses.
This comes a month after the regulators said it made sense to “administer COVID-19 vaccine boosters as early as three months after the initial two-shot regimen,” amid concerns over the Omicron variant.
The World Health Organization’s Technical Advisory Group on COVID-19 Vaccine Composition on Jan. 11 also warned, “a vaccination strategy based on repeated booster doses of the original vaccine composition is unlikely to be appropriate or sustainable.”
The group said giving additional doses of already existing vaccines as new strains of the virus emerge is not the best way to fight a pandemic, as currently available COVID vaccines do not prevent infection or transmission and the current composition of COVID vaccines need to be updated.
Djokovic’s visa canceled second time over unvaccinated status
Australian authorities today revoked Novak Djokovic’s visa due to his unvaccinated status, in the latest twist in the ongoing battle over whether the nine-time Australian Open champion will be allowed to defend his title.
As The Defender reported, Australian Minister Alex Hawke used his ministerial discretion to cancel the No. 1 ranked Tennis player’s visa citing “health or good order grounds,” just three days before the Australian Open begins and four days after a federal judge ordered Djokovic be released from hotel detention when his visa was revoked the first time.
Djokovic’s lawyers are contesting the visa cancellation in court, in an attempt to allow him to play in the prestigious tennis tournament. If unsuccessful, Djokovic will face deportation.